ClinicalTrials.Veeva

Menu

Cyclophotocoagulation in Primary Open Angle Glaucoma

Cairo University (CU) logo

Cairo University (CU)

Status

Unknown

Conditions

Primary Open Angle Glaucoma

Treatments

Procedure: Cyclophotocoagulation

Study type

Interventional

Funder types

Other

Identifiers

NCT04430296
18/5/2020-1

Details and patient eligibility

About

The use of Cyclodestruction procedures has been extended to patients with non-refractory glaucoma and good vision. Our aim is to compare the safety and efficacy of three cyclodestructive treatments; High Intensity Focused Ultrasound (HIFU) Cyclocoagulation versus micropulse cyclophotocoagulation (MP-CPC) versus transscleral continuous wave cyclophotocoagulation (CW-CPC) for the treatment of Primary open angle glaucoma.

Enrollment

78 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • medically uncontrolled, primary open angle glaucoma attending glaucoma clinic

Exclusion criteria

  • patients with history of previous laser or surgical intervention

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

78 participants in 3 patient groups

High Intensity Focused Ultrasound Cyclophotocoagulation (HIFU)
Active Comparator group
Treatment:
Procedure: Cyclophotocoagulation
MicroPulse cyclophotocoagulation (MP-CPC)
Active Comparator group
Treatment:
Procedure: Cyclophotocoagulation
Continuous Wave cyclophotocoagulation (CW-CPC)
Active Comparator group
Treatment:
Procedure: Cyclophotocoagulation

Trial contacts and locations

0

Loading...

Central trial contact

Ahmed M Abdelrahman, MD; Heba M ElSaied, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems